{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:59Z","timestamp":1787509199642,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Epithelial ovarian cancer (EOC) is the leading cause of death among gynecological malignancies, and the tumors with advanced-stage are frequently characterized by extensive metastasis. Although metabolic reprogramming of amino acids represents a hallmark of cancer, its specific role in the metastatic progression of EOC remains poorly understood. Here, we identified a critical metabolic vulnerability in omental metastasis of EOC. Despite defective endogenous synthesis, arginine accumulation depends on exogenous uptake. In vivo experiments demonstrated that dietary arginine deprivation suppressed tumor growth and metastasis, whereas supplementation or enhanced uptake of arginine promoted tumor cell proliferation, invasion, and migration in vitro. Mechanistically, increased arginine binds to the RNA helicase DDX3X, inducing nuclear retention of DDX3X and further promoting the transcription of DNA damage response (DDR)-related genes, thereby facilitating DDR through activating the ATM\/CHK2\/P53 axis to enable cancer cells to survive under metastatic stress. Notably, arginine restriction or pharmacological inhibition of DDX3X did effectively suppress both primary tumor growth and omental metastasis in mouse models. Collectively, our findings reveal that arginine is a metabolic vulnerability in omental metastasis of EOC, indicating that arginine restriction and DDX3X inhibition represent promising therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41419-026-08606-3","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:15:59Z","timestamp":1774340159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Arginine dependency in omental metastasis of epithelial ovarian cancer reveals a therapeutic vulnerability"],"prefix":"10.1038","volume":"17","author":[{"given":"Jiming","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehan","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongdong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3036-3296","authenticated-orcid":false,"given":"Yongxiu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"8606_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8606_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13045-024-01623-9","volume":"17","author":"W Li","year":"2024","unstructured":"Li W, Liang H, Wang W, Liu J, Liu X, Lao S, et al. Global cancer statistics for adolescents and young adults: population based study. J Hematol Oncol. 2024;17:99.","journal-title":"J Hematol Oncol"},{"key":"8606_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/AOG.0000000000004642","volume":"139","author":"JK Chan","year":"2022","unstructured":"Chan JK, Tian C, Kesterson JP, Monk BJ, Kapp DS, Davidson B, et al. Symptoms of women with high-risk early-stage ovarian cancer. Obstet Gynecol. 2022;139:157\u201362.","journal-title":"Obstet Gynecol"},{"key":"8606_CR4","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/cancers11081044","volume":"11","author":"N Thomakos","year":"2019","unstructured":"Thomakos N, Diakosavvas M, Machairiotis N, Fasoulakis Z, Zarogoulidis P, Rodolakis A. Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature. Cancers. 2019;11:1044","journal-title":"Cancers"},{"key":"8606_CR5","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1016\/j.ccell.2024.08.016","volume":"42","author":"E Bayraktar","year":"2024","unstructured":"Bayraktar E, Chen S, Corvigno S, Liu J, Sood AK. Ovarian cancer metastasis: looking beyond the surface. Cancer Cell. 2024;42:1631\u20136.","journal-title":"Cancer Cell"},{"key":"8606_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmet.2022.01.007","volume":"34","author":"NN Pavlova","year":"2022","unstructured":"Pavlova NN, Zhu J, Thompson CB. The hallmarks of cancer metabolism: still emerging. Cell Metab. 2022;34:355\u201377.","journal-title":"Cell Metab"},{"key":"8606_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41568-020-00320-2","volume":"21","author":"G Bergers","year":"2021","unstructured":"Bergers G, Fendt S-M. The metabolism of cancer cells during metastasis. Nat Rev Cancer. 2021;21:162\u201380.","journal-title":"Nat Rev Cancer"},{"key":"8606_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.cell.2024.10.047","volume":"188","author":"Y Wang","year":"2025","unstructured":"Wang Y, Hu M, Cao J, Wang F, Han JR, Wu TW. et al. ACSL4 and polyunsaturated lipids support metastatic extravasation and colonization. Cell. 2025;188:412\u201329.e27.","journal-title":"Cell"},{"key":"8606_CR9","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.cmet.2023.10.002","volume":"35","author":"J Li","year":"2023","unstructured":"Li J, Zheng C, Mai Q, Huang X, Pan W, Lu J. et al. Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancer. Cell Metab. 2023;35:2044\u201359.","journal-title":"Cell Metab"},{"key":"8606_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41416-019-0620-5","volume":"122","author":"L Vettore","year":"2020","unstructured":"Vettore L, Westbrook RL, Tennant DA. New aspects of amino acid metabolism in cancer. Br J Cancer. 2020;122:150\u20136.","journal-title":"Br J Cancer"},{"key":"8606_CR11","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/j.gastro.2022.11.014","volume":"164","author":"S Solanki","year":"2023","unstructured":"Solanki S, Sanchez K, Ponnusamy V, Kota V, Bell HN, Cho C-S. et al. Dysregulated amino acid sensing drives colorectal cancer growth and metabolic reprogramming leading to chemoresistance. Gastroenterology. 2023;164:376\u201391.e13.","journal-title":"Gastroenterology"},{"key":"8606_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41586-024-08335-7","volume":"638","author":"G Doglioni","year":"2025","unstructured":"Doglioni G, Fern\u00e1ndez-Garc\u00eda J, Igelmann S, Altea-Manzano P, Blomme A, La Rovere R, et al. Aspartate signalling drives lung metastasis via alternative translation. Nature. 2025;638:244\u201350.","journal-title":"Nature"},{"key":"8606_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.cmet.2022.06.010","volume":"34","author":"R Missiaen","year":"2022","unstructured":"Missiaen R, Anderson NM, Kim LC, Nance B, Burrows M, Skuli N. GCN2 inhibition sensitizes arginine-deprived hepatocellular carcinoma cells to senolytic treatment. Cell Metab. 2022;34:1151\u201367.e7.","journal-title":"Cell Metab"},{"key":"8606_CR14","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.cell.2023.09.011","volume":"186","author":"D Mossmann","year":"2023","unstructured":"Mossmann D, M\u00fcller C, Park S, Ryback B, Colombi M, Ritter N. et al. Arginine reprograms metabolism in liver cancer via RBM39. Cell. 2023;186:5068\u201383.e23.","journal-title":"Cell"},{"key":"8606_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41556-018-0125-0","volume":"20","author":"LB Sullivan","year":"2018","unstructured":"Sullivan LB, Luengo A, Danai LV, Bush LN, Diehl FF, Hosios AM, et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat Cell Biol. 2018;20:782\u20138.","journal-title":"Nat Cell Biol"},{"key":"8606_CR16","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1080\/15548627.2019.1586255","volume":"15","author":"Y Hao","year":"2019","unstructured":"Hao Y, Kacal M, Ouchida AT, Zhang B, Norberg E, Vakifahmetoglu-Norberg H. Targetome analysis of chaperone-mediated autophagy in cancer cells. Autophagy. 2019;15:1558\u201371.","journal-title":"Autophagy"},{"key":"8606_CR17","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s41586-023-06421-w","volume":"620","author":"ZRC Marks","year":"2023","unstructured":"Marks ZRC, Campbell NK, Mangan NE, Vandenberg CJ, Gearing LJ, Matthews AY, et al. Interferon-\u03b5 is a tumour suppressor and restricts ovarian cancer. Nature. 2023;620:1063\u201370.","journal-title":"Nature"},{"key":"8606_CR18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/7651_2019_259","volume":"2109","author":"S Martinotti","year":"2020","unstructured":"Martinotti S, Ranzato E. Scratch wound healing assay. Methods Mol Biol. 2020;2109:225\u20139.","journal-title":"Methods Mol Biol"},{"key":"8606_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.766077","volume":"12","author":"J Tian","year":"2022","unstructured":"Tian J, Liang X, Wang D, Tian J, Liang H, Lei T, et al. TBC1D2 promotes ovarian cancer metastasis via inducing e-cadherin degradation. Front Oncol. 2022;12:766077.","journal-title":"Front Oncol"},{"key":"8606_CR20","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.ymthe.2022.01.032","volume":"30","author":"D Wang","year":"2022","unstructured":"Wang D, Tian J, Yan Z, Yuan Q, Wu D, Liu X, et al. Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors. Mol Ther. 2022;30:1645\u201360.","journal-title":"Mol Ther"},{"key":"8606_CR21","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1038\/s43018-023-00599-8","volume":"4","author":"X Zheng","year":"2023","unstructured":"Zheng X, Wang X, Cheng X, Liu Z, Yin Y, Li X, et al. Single-cell analyses implicate ascites in remodeling the ecosystems of primary and metastatic tumors in ovarian cancer. Nat Cancer. 2023;4:1138\u201356.","journal-title":"Nat Cancer"},{"key":"8606_CR22","doi-asserted-by":"crossref","unstructured":"Mollaoglu G, Tepper A, Falcomat\u00e0 C, Potak HT, Pia L, Amabile A, et al. Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell. 2024;187:7492\u2013510.e22.","DOI":"10.1016\/j.cell.2024.10.006"},{"key":"8606_CR23","doi-asserted-by":"crossref","unstructured":"Geiger R, Rieckmann JC, Wolf T, Basso C, Feng Y, Fuhrer T, et al. L-Arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell. 2016;167:829\u201342.e13.","DOI":"10.1016\/j.cell.2016.09.031"},{"key":"8606_CR24","doi-asserted-by":"crossref","unstructured":"Shen H, Yanas A, Owens MC, Zhang C, Fritsch C, Fare CM, et al. Sexually dimorphic RNA helicases DDX3X and DDX3Y differentially regulate RNA metabolism through phase separation. Mol Cell. 2022;82:2588\u2013603.e9.","DOI":"10.1016\/j.molcel.2022.04.022"},{"key":"8606_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114248","volume":"43","author":"X Zhang","year":"2024","unstructured":"Zhang X, Han L, Hou J, Yang H, Xu H, Li G, et al. Stress granule-localized USP8 potentiates cGAS-mediated type I interferonopathies through deubiquitination of DDX3X. Cell Rep. 2024;43:114248.","journal-title":"Cell Rep"},{"key":"8606_CR26","doi-asserted-by":"crossref","unstructured":"Chen C-L, Hsu S-C, Ann DK, Yen Y, Kung H-J. Arginine signaling and cancer metabolism. Cancers. 2021;13:3541.","DOI":"10.3390\/cancers13143541"},{"key":"8606_CR27","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejcb.2018.08.001","volume":"97","author":"R Brennan","year":"2018","unstructured":"Brennan R, Haap-Hoff A, Gu L, Gautier V, Long A, Schr\u00f6der M. Investigating nucleo-cytoplasmic shuttling of the human DEAD-box helicase DDX3. Eur J Cell Biol. 2018;97:501\u201311.","journal-title":"Eur J Cell Biol"},{"key":"8606_CR28","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1016\/j.ajpath.2018.06.008","volume":"188","author":"LM van der Waals","year":"2018","unstructured":"van der Waals LM, Jongen JMJ, Elias SG, Veremiyenko K, Trumpi K, Trinh A, et al. Increased levels of oxidative damage in liver metastases compared with corresponding primary colorectal tumors: association with molecular subtype and prior treatment. Am J Pathol. 2018;188:2369\u201377.","journal-title":"Am J Pathol"},{"key":"8606_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111012","volume":"39","author":"S Bose","year":"2022","unstructured":"Bose S, Huang Q, Ma Y, Wang L, Rivera GO, Ouyang Y, et al. G6PD inhibition sensitizes ovarian cancer cells to oxidative stress in the metastatic omental microenvironment. Cell Rep. 2022;39:111012.","journal-title":"Cell Rep"},{"key":"8606_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang R, Zhou P-K. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct Target Ther. 2021;6:254.","journal-title":"Signal Transduct Target Ther"},{"key":"8606_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.15252\/emmm.201404368","volume":"7","author":"GM Bol","year":"2015","unstructured":"Bol GM, Vesuna F, Xie M, Zeng J, Aziz K, Gandhi N, et al. Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. EMBO Mol Med. 2015;7:648\u201369.","journal-title":"EMBO Mol Med"},{"key":"8606_CR32","doi-asserted-by":"crossref","unstructured":"Zhang Y, Yu H, Zhang J, Gao H, Wang S, Li S, et al. Cul4A-DDB1-mediated monoubiquitination of phosphoglycerate dehydrogenase promotes colorectal cancer metastasis via increased S-adenosylmethionine. J Clin Invest. 2021;131:e146187.","DOI":"10.1172\/JCI146187"},{"key":"8606_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15267","volume":"8","author":"I Elia","year":"2017","unstructured":"Elia I, Broekaert D, Christen S, Boon R, Radaelli E, Orth MF, et al. Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat Commun. 2017;8:15267.","journal-title":"Nat Commun"},{"key":"8606_CR34","doi-asserted-by":"crossref","unstructured":"Torrino S, Grasset EM, Audebert S, Belhadj I, Lacoux C, Haynes M, et al. Mechano-induced cell metabolism promotes microtubule glutamylation to force metastasis. Cell Metab. 2021;33:1342\u201357.e10.","DOI":"10.1016\/j.cmet.2021.05.009"},{"key":"8606_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s42255-023-00818-7","volume":"5","author":"L Qian","year":"2023","unstructured":"Qian L, Li N, Lu X-C, Xu M, Liu Y, Li K, et al. Enhanced BCAT1 activity and BCAA metabolism promotes RhoC activity in cancer progression. Nat Metab. 2023;5:1159\u201373.","journal-title":"Nat Metab"},{"key":"8606_CR36","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, Kersten K, Maller O, Timblin GA, Stashko C, Canale FP, et al. Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5:1045\u201362.","journal-title":"Nat Cancer"},{"key":"8606_CR37","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1158\/1078-0432.CCR-12-2641","volume":"19","author":"H-Y Huang","year":"2013","unstructured":"Huang H-Y, Wu W-R, Wang Y-H, Wang J-W, Fang F-M, Tsai J-W, et al. ASS1 as a novel tumor suppressor gene in myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. Clin Cancer Res. 2013;19:2861\u201372.","journal-title":"Clin Cancer Res"},{"key":"8606_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1001\/jamaoncol.2016.3049","volume":"3","author":"PW Szlosarek","year":"2017","unstructured":"Szlosarek PW, Steele JP, Nolan L, Gilligan D, Taylor P, Spicer J, et al. Arginine deprivation with pegylated arginine deiminase in patients with argininosuccinate synthetase 1-deficient malignant pleural mesothelioma: a randomized clinical trial. JAMA Oncol. 2017;3:58\u201366.","journal-title":"JAMA Oncol"},{"key":"8606_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.cell.2015.02.041","volume":"161","author":"L Chantranupong","year":"2015","unstructured":"Chantranupong L, Wolfson RL, Sabatini DM. Nutrient-sensing mechanisms across evolution. Cell. 2015;161:67\u201383.","journal-title":"Cell"},{"key":"8606_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22652-9","volume":"12","author":"C-L Chen","year":"2021","unstructured":"Chen C-L, Hsu S-C, Chung T-Y, Chu C-Y, Wang H-J, Hsiao P-W, et al. Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells. Nat Commun. 2021;12:2398.","journal-title":"Nat Commun"},{"key":"8606_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01325-7","volume":"20","author":"J Mo","year":"2021","unstructured":"Mo J, Liang H, Su C, Li P, Chen J, Zhang B. DDX3X: structure, physiologic functions and cancer. Mol Cancer. 2021;20:38.","journal-title":"Mol Cancer"},{"key":"8606_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2021.103137","volume":"103","author":"MJ Cargill","year":"2021","unstructured":"Cargill MJ, Morales A, Ravishankar S, Warren EH. RNA helicase, DDX3X, is actively recruited to sites of DNA damage in live cells. DNA Repair. 2021;103:103137.","journal-title":"DNA Repair"},{"key":"8606_CR43","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1158\/0008-5472.CAN-16-0440","volume":"76","author":"M Xie","year":"2016","unstructured":"Xie M, Vesuna F, Tantravedi S, Bol GM, Heerma van Voss MR, Nugent K, et al. RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3. Cancer Res. 2016;76:6340\u201350.","journal-title":"Cancer Res"},{"key":"8606_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adw9519","volume":"11","author":"Y Wang","year":"2025","unstructured":"Wang Y, Yang Q, Lin F, Song X, Yang G, Wen D, et al. RNA binding protein DDX3X drives pancreatic cancer progression via the TLE2-MYL9 axis. Sci Adv. 2025;11:eadw9519.","journal-title":"Sci Adv"},{"key":"8606_CR45","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1158\/0008-5472.CAN-23-3829","volume":"84","author":"W-J Hsu","year":"2024","unstructured":"Hsu W-J, Chiang M-C, Chao Y-C, Chang Y-C, Hsu M-C, Chung C-H, et al. Arginine methylation of DDX3 by PRMT1 mediates mitochondrial homeostasis to promote breast cancer metastasis. Cancer Res. 2024;84:3023\u201343.","journal-title":"Cancer Res"},{"key":"8606_CR46","doi-asserted-by":"crossref","unstructured":"Ovejero-S\u00e1nchez M, Gonz\u00e1lez-Sarmiento R, Herrero AB. DNA damage response alterations in ovarian cancer: from molecular mechanisms to therapeutic opportunities. Cancers. 2023;15:448.","DOI":"10.3390\/cancers15020448"},{"key":"8606_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12505","volume":"13","author":"Y Ma","year":"2024","unstructured":"Ma Y, Guo J, Rao H, Xin J, Song X, Liu R, et al. The 8-oxoguanine DNA glycosylase-synaptotagmin 7 pathway increases extracellular vesicle release and promotes tumour metastasis during oxidative stress. J Extracell Vesicles. 2024;13:e12505.","journal-title":"J Extracell Vesicles"},{"key":"8606_CR48","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1158\/0008-5472.CAN-25-1085","volume":"85","author":"A Papargyriou","year":"2025","unstructured":"Papargyriou A, Reichert M. The biology in the pattern: metastatic organotropism and clinical outcome depend on DNA damage response and immune interactions in pancreatic cancer. Cancer Res. 2025;85:1571\u20133.","journal-title":"Cancer Res"},{"key":"8606_CR49","first-page":"5597","volume":"8","author":"L Mei","year":"2015","unstructured":"Mei L, Hu Q, Peng J, Ruan J, Zou J, Huang Q, et al. Phospho-histone H2AX is a diagnostic and prognostic marker for epithelial ovarian cancer. Int J Clin Exp Pathol. 2015;8:5597\u2013602.","journal-title":"Int J Clin Exp Pathol"},{"key":"8606_CR50","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/s42255-024-01060-5","volume":"6","author":"LQJ Lim","year":"2024","unstructured":"Lim LQJ, Adler L, Hajaj E, Soria LR, Perry RB-T, Darzi N, et al. ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response. Nat Metab. 2024;6:1294\u2013309.","journal-title":"Nat Metab"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08606-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08606-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:02:41Z","timestamp":1774987361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08606-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8606"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08606-3","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Present study was approved by Ethics Committee of the First Hospital of Lanzhou University (LDYYLL2024-130). Animal experiments were approved by the Institutional Animal Care and Use Committee of the First Hospital of Lanzhou University (LDYYLL2024-51).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"354"}}